Odery Ramos Jr
@OderyJrProfessor of GI @ufpr @faculevangelica Chief of GI and Vice-Chief of Medicine @chcufpr Former President @BRASPEN_SBNPE Interests: #IBD #microbiome #nutrition
Similar User
@HorstIBDDoc
@DarrellPardi
@KNWeaverMD
@GuiRamosMD
@JeanDonet
@dunleavy_katie
@EricJVargasMD
@sang_hyoung
@AdamBledsoeMD
@NayantaraCoelho
@AdamFayeMD
@amjohnsonMD
@SLHanselMD
@BDYE_IBD
@Muni_Kurtz
Grateful to @AmerGastroAssn for supporting our initial work using intestinal #organoids to understand the factors governing secretory lineage differentiation in health and disease @MdBreault @MayoClinicGIHep
We’re proud to announce that the #AGAResearchFoundation will award $2.64 million to support 79 promising researchers working to advance GI patient care. Join us in congratulating the awardees! ⭐ ow.ly/a8RH50RyIlO
NYC Marathon ✅🗽 Another great experience alongside Team Challenge 🏃 raising >$200k to support @CrohnsColitisFn ! Special thanks to @KatGunsur and Coach Marc leading us through the finish line @nycmarathon , and to everyone that donated: I brought you along the 26.2 miles!
Family business @DDWMeeting 🤍👊🏼 #DDW2023 @OderyJr @GuiRamosMD @ManuelBragaMD
Bouveret’s syndrome occurs when a gallstone fistulates from the gallbladder into the duodenum 🔴, resulting in gastric outlet obstruction 🟡. Pneumobilia (air in bile ducts) can also be seen ⚪️ Image credit: @GuiRamosMD nejm.org/doi/10.1056/NE…
🚨In this month’s edition of @AGA_Gastro our group @FaubionWilliam Lab, shows how inhibitors of the epigenetic enzyme G9a can metabolic reprogram Tcells into Treg capable of controlling Intestinal Inflammation. Cell engineering & Epigenetic Modulation as potential novel #IBD txs
Thank you @MayoClinic for amplifying our work! We continue our efforts to engineer cells as novel treatments for #IBD @MayoClinicGIHep with the @FaubionWilliam lab team: @WaleBamidelePhD @mmgonzalezmd @BrookeDruliner @Ahmed_Kurdi_88 discoverysedge.mayo.edu/2022/11/09/stu…
Thankful for the amazing experience over the past few months @MayoClinicGIHep ! Special thanks to my mentor, Dr Camilleri: a wonderful human-being & master clinician. Beyond GI motility, you taught me how to treat people and be person! It’s been an honor to learn from the best!!
A New Year, New Therapies! An #IBD #medtwitter #tweetorial As a late ring into the New Year, let’s explore Novel #IBD Agents coming to practice! Our Aims: 1️⃣ Understand the Nomenclature 2️⃣ Revise Currently Available Drugs 3️⃣ Discuss Mechanisms & Adverse Events of Novel Agents
Sleep faculty @erikstlouis and colleagues review the current concepts in the therapeutics of #REM #sleep behavior disorder (#RBD) and identify pertinent research questions to be addressed by future work. pubmed.ncbi.nlm.nih.gov/33410105/
Dr. Charles Mayo and Dr. William Mayo always referred to each other as part of a team "my brother and I". Manuel e Guilherme, IBD fellows, have been doing the same for the past 7 years. I am happy to see Mayo Clinic`s spirit among them and extremely proud of their work here.
Check @DrKPennington tomorrow, January 3 at 7PM EST @CPSolvers @Rafameed
Be sure to tune in to @DrKPennington tomorrow, January 3, at 7 PM EST for subspecialty virtual morning report with @CPSolvers! #MedTwitter
🏆 12/12/18 🏆 20/11/21 TÁ NA HISTÓRIA! BICAMPEÃO!!!!!!! #AméricaAthleticana #FuracãoBicampeão #Athletico
🔴⚫️ ¡CAMPEÓN! @AthleticoPR ganó la CONMEBOL #Sudamericana 2⃣0⃣2⃣1⃣ y alcanzó por segunda vez en su historia #LaGranConquista 🇧🇷🏆
Consenso latinoamericano acerca de indicadores de calidad en EII de PANCCO-GETECCU. Muy bueno trabajo!
Back-to-Back 🥇 🇧🇷 💪🏻
👏 Congratulations to 2021 Gastroenterology Fellowship graduate, @GuiRamosMD! We are very proud of you, and we are so glad you are staying with us for another year as you pursue further training in our IBD Advanced Fellowship! We know you will do great things.
👏 CONGRATULATIONS to our 2021 @MayoClinic Rochester Gastroenterology Fellowship graduates. All of us are extremely proud of each of you, and we know that you will do great things and make astounding contributions to the field of gastroenterology. @LauraRaffalsMD @DougSimonetto
When a new drug is approved in your field, it is a good practice to go through the prescribing information in detail. There is a *lot* to unpack in the #Ozanimod PI. Let's take a tour (THREAD)
Hot off the press, @US_FDA approves Zeposia (ozanimod) for moderately to severely active #UC. New mechanism of action for our patients. This is an S1P receptor modulator that prevents activated WBCs from migrating. Once daily, oral. businesswire.com/news/home/2021…
Certolizumab Trough Levels and Antibodies in Crohn’s Disease: A Single-Center Experience academic.oup.com/crohnscolitis3… @GuiRamosMD @Badr_AlBawardy @ManuelBragaMD @AdamBledsoeMD @KQuinnMD @valerie_heron @malicewi @amjohnsonMD @NayantaraCoelho @DrJohnKisiel @DarrellPardi @IBDJournals
United States Trends
- 1. Knicks 22,8 B posts
- 2. Hawks 25,6 B posts
- 3. Trae Young 11,2 B posts
- 4. #Survivor47 6.808 posts
- 5. #AEWDynamite 14,1 B posts
- 6. Brunson 12,6 B posts
- 7. Rachel 52,7 B posts
- 8. Jalen Johnson 2.590 posts
- 9. $PLUR 6.175 posts
- 10. Bill Belichick 42,8 B posts
- 11. #SistasOnBET 1.247 posts
- 12. Dyson Daniels 1.399 posts
- 13. Shams 8.679 posts
- 14. #TrueToAtlanta N/A
- 15. #TheChallenge40 N/A
- 16. Colgate 2.080 posts
- 17. Ospreay 2.322 posts
- 18. Deandre Hunter N/A
- 19. Rich Rod 2.755 posts
- 20. Adam Cole 1.167 posts
Who to follow
-
Sara Horst MD, MPH, FACG
@HorstIBDDoc -
Darrell Pardi
@DarrellPardi -
Kim Weaver MD
@KNWeaverMD -
Gui Ramos MD
@GuiRamosMD -
Jean Donet
@JeanDonet -
Katie Dunleavy
@dunleavy_katie -
Eric J. Vargas M.D. M.S. ABOM
@EricJVargasMD -
Sang Hyoung Park
@sang_hyoung -
Adam Bledsoe, MD
@AdamBledsoeMD -
Nayantara Coelho
@NayantaraCoelho -
Adam Faye MD MS
@AdamFayeMD -
Amanda Johnson, MD
@amjohnsonMD -
Stephanie Hansel
@SLHanselMD -
Byong Duk Ye
@BDYE_IBD -
Munique Kurtz de Mello
@Muni_Kurtz
Something went wrong.
Something went wrong.